Trial Profile
Systemic Absorption of Bevacizumab and Ranibizumab in Humans Treated for Diabetic Macular Edema
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Jun 2019
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Ranibizumab (Primary)
- Indications Diabetic macular oedema
- Focus Pharmacokinetics
- 01 Aug 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 20 Aug 2012 New trial record